[Lecture Report] The 10th NIKKEI FT Communicable Diseases Conference (Nikkei Inc., October 16-18, 2023, Tokyo, Chiyoda-ku)
date : 12/7/2023
Tags: AMR, Global Health, Vaccinations
On October 16-18, 2023, HGPI Chairman Dr. Kiyoshi Kurokawa, CEO and Board Member Mr. Ryoji Noritake, and Vice President Mr. Joji Sugawara spoke at various programs throughout each day of the 10th NIKKEI FT Communicable Diseases Conference, organized by Nikkei Inc. and co-sponsored by Financial Times.
For details, please visit the event website, which can be found here.

Below is an excerpt from the program that included Dr. Kurokawa and Mr. Noritake, Mr. Sugawara.
October 17 (Tue)
Special Session 1 Establishing a Drug Discovery Ecosystem for Infectious Disease Area – A Year in Review and Future Initiatives –
Moderator: Ryoji Noritake (CEO and Board Member, Health and Global Policy Institute)
Special Session 2 Importance of Novel Antibacterial Drugs, and Global Collaboration for Expansion of Necessary Pull-type Incentives
Moderator: Ryoji Noritake (CEO and Board Member, Health and Global Policy Institute)
Agenda 4 – Making Unpredictable Communicable Disease Predictable by Economic Incentives and R&D
Moderator: Ryoji Noritake (CEO and Board Member, Health and Global Policy Institute)
Breakout Session D Significance and Challenges of Infectious Diseases Control in Companies
Discusser: Joji Sugawara (Vice President, Health and Global Policy Institute)
October 18 (Wed)
Special Session 4 Making Breakthroughs With Japan -Toward Accelerating Open Innovation in Japan-
Moderator: Ryoji Noritake (CEO and Board Member, Health and Global Policy Institute)
Summary Session / Conclusion / Statement
Panelist:
Kiyoshi Kurokawa (Chairman, Health and Global Policy Institute)
Ryoji Noritake (CEO and Board Member, Health and Global Policy Institute)
Top Research & Recommendations Posts
- [Policy Recommendations] Improving Patient Access to Genomic Cancer Medicine (August 10, 2023)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Event Report and Discussion Points] AI Diagnostic Support Project Expert Meeting: “The Roles of Industry, Government, Academia, and Civil Society in the Era of AI-Assisted Diagnosis” (May 25, 2026)
- [Public Comment Submission] “The 7th Science, Technology and Innovation Basic Plan” (Draft) (February 19, 2026)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Policy Recommendations] Policy Recommendations in the Field of Blood Disorders “Building a Healthcare Ecosystem Centered on Patients and Those Affected” (April 13, 2026)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
Featured Posts
-
2026-05-13
[Registration Open] HGPI Salon 2025-2026 Looking Ahead to the Future of Japan’s Social Security System “Session 5: The Value of Healthcare in Society – Perspectives from the Reiwa Era” (June 29, 2026)
-
2026-06-04
[Registration Open] (Webinar) The 3rd J-PEP Seminar “Social Participation of People with Intractable Diseases and the Potential of a New Way of Working — ‘RD Workers’ — Lessons from Policy Advocacy Practice” (July 22, 2026)
-
2026-06-15
[Registration Open] (Hybrid Format) Multidisciplinary Symposium for Cardiology, Nephrology, and Metabolic Medicine “Future Actions for Making Full Use of the Health Checkup System: Connecting Checkups to Treatment From the Perspective of Data Linkage” (July 6, 2026)



